Michael G. Kelly

CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA.

Trinds LLC operates as a contract research organization which conducts research in neuromuscular and rare disorders. It offers solutions in clinical operations, data management, patient science liaison services, study measurements, and biostatistics. The company was founded by Avital Cnaan, Heather Gordish-Dressman and Eric Hoffman and is headquartered in Pittsburgh, PA.

Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA

NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA

Myotherix, Inc. operates as a biopharmaceutical company focuses on the development of therapies. It focuses on the development of innovative therapies for patients suffering from Duchenne muscular dystrophy and other muscle disorders for which there are no treatments. The company was founded by John Kincaid and is headquartered in Emeryville, CA.